These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33736815)

  • 1. Antibody-free enrichment method for proteome-wide analysis of endogenous SUMOylation sites.
    Li Y; Sun M; Hu Y; Shan Y; Liang Z; Zhang L; Zhang Y
    Anal Chim Acta; 2021 Apr; 1154():338324. PubMed ID: 33736815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific identification and quantitation of endogenous SUMOylation based on SUMO-specific protease and strong anion exchange chromatography.
    Li Y; Sun M; Sui Z; Zhang Z; Shan Y; Zhang L; Zhang Y
    J Chromatogr A; 2024 Aug; 1730():465064. PubMed ID: 38865749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteome-wide Mapping of Endogenous SUMOylation Sites in Mouse Testis.
    Cai L; Tu J; Song L; Gao Z; Li K; Wang Y; Liu Y; Zhong F; Ge R; Qin J; Ding C; He F
    Mol Cell Proteomics; 2017 May; 16(5):717-727. PubMed ID: 28289178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of endogenous SUMO1 accepter sites by mass spectrometry.
    Hsiao HH; Meulmeester E; Urlaub H
    Methods Mol Biol; 2012; 893():431-41. PubMed ID: 22665316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting endogenous SUMO targets in mammalian cells and tissues.
    Becker J; Barysch SV; Karaca S; Dittner C; Hsiao HH; Berriel Diaz M; Herzig S; Urlaub H; Melchior F
    Nat Struct Mol Biol; 2013 Apr; 20(4):525-31. PubMed ID: 23503365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specific characterization of endogenous SUMOylation across species and organs.
    Hendriks IA; Lyon D; Su D; Skotte NH; Daniel JA; Jensen LJ; Nielsen ML
    Nat Commun; 2018 Jun; 9(1):2456. PubMed ID: 29942033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific identification and quantitation of endogenous SUMO modifications under native conditions.
    Lumpkin RJ; Gu H; Zhu Y; Leonard M; Ahmad AS; Clauser KR; Meyer JG; Bennett EJ; Komives EA
    Nat Commun; 2017 Oct; 8(1):1171. PubMed ID: 29079793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative SUMO Proteome Analysis Using Stable Isotopic Labeling by Amino Acids (SILAC).
    Chachami G; Barysch SV
    Methods Mol Biol; 2023; 2603():71-86. PubMed ID: 36370271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteome-wide identification of SUMO2 modification sites.
    Tammsalu T; Matic I; Jaffray EG; Ibrahim AFM; Tatham MH; Hay RT
    Sci Signal; 2014 Apr; 7(323):rs2. PubMed ID: 24782567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. System-wide identification of wild-type SUMO-2 conjugation sites.
    Hendriks IA; D'Souza RC; Chang JG; Mann M; Vertegaal AC
    Nat Commun; 2015 Jun; 6():7289. PubMed ID: 26073453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMO-Binding Entities (SUBEs) as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer.
    Lopitz-Otsoa F; Delgado TC; Lachiondo-Ortega S; Azkargorta M; Elortza F; Rodríguez MS; Martínez-Chantar ML
    J Vis Exp; 2019 Nov; (153):. PubMed ID: 31736480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted identification of SUMOylation sites in human proteins using affinity enrichment and paralog-specific reporter ions.
    Lamoliatte F; Bonneil E; Durette C; Caron-Lizotte O; Wildemann D; Zerweck J; Wenshuk H; Thibault P
    Mol Cell Proteomics; 2013 Sep; 12(9):2536-50. PubMed ID: 23750026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Sumoylation.
    Breucker J; Pichler A
    Methods Mol Biol; 2019; 1934():223-233. PubMed ID: 31256382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMOylation Landscape of Renal Cortical Collecting Duct Cells.
    Wu Q; Aroankins TS; Cheng L; Fenton RA
    J Proteome Res; 2019 Oct; 18(10):3640-3648. PubMed ID: 31502464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cross talk between SUMOylation and ubiquitylation using a sequential peptide immunopurification approach.
    McManus FP; Lamoliatte F; Thibault P
    Nat Protoc; 2017 Nov; 12(11):2342-2358. PubMed ID: 29048423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and analysis of endogenous SUMO1 and SUMO2/3 targets in mammalian cells and tissues using monoclonal antibodies.
    Barysch SV; Dittner C; Flotho A; Becker J; Melchior F
    Nat Protoc; 2014 Apr; 9(4):896-909. PubMed ID: 24651501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.
    Hendriks IA; Lyon D; Young C; Jensen LJ; Vertegaal AC; Nielsen ML
    Nat Struct Mol Biol; 2017 Mar; 24(3):325-336. PubMed ID: 28112733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach to the analysis of SUMOylation with the independent use of trypsin and elastase digestion followed by database searching utilising consecutive residue addition to lysine.
    Chicooree N; Griffiths JR; Connolly Y; Tan CT; Malliri A; Eyers CE; Smith DL
    Rapid Commun Mass Spectrom; 2013 Jan; 27(1):127-34. PubMed ID: 23239325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody-based systematic identification of SUMO1-modification sites reveals TFII-I SUMOylation is involved in tumor growth.
    Chen Y; Liu K; Zhang G; Cheng J; Tu J
    J Cell Physiol; 2024 Mar; 239(3):e31080. PubMed ID: 37450667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.
    Chung TL; Hsiao HH; Yeh YY; Shia HL; Chen YL; Liang PH; Wang AH; Khoo KH; Shoei-Lung Li S
    J Biol Chem; 2004 Sep; 279(38):39653-62. PubMed ID: 15272016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.